Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

Research output: Contribution to journal › Article › peer-review

ASJC Scopus Subject Areas

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{912e151fe1d640ea918a0e4028d92a75,

title = "Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland",

note = "Publisher Copyright: {\textcopyright} 2022, The Author(s).",

year = "2022",

month = dec,

doi = "10.1038/s41467-022-32264-6",

language = "English",

volume = "13",

journal = "Nature Communications",

issn = "2041-1723",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

PY - 2022/12

Y1 - 2022/12

UR - http://www.scopus.com/inward/record.url?scp=85135990893&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85135990893&partnerID=8YFLogxK

U2 - 10.1038/s41467-022-32264-6

DO - 10.1038/s41467-022-32264-6

M3 - Article

C2 - 35970827

AN - SCOPUS:85135990893

SN - 2041-1723

VL - 13

JO - Nature Communications

JF - Nature Communications

IS - 1

M1 - 4800

ER -